DP

Diadema Partners Portfolio holdings

AUM $168M
1-Year Est. Return 163.97%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+163.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$144M
AUM Growth
-$17.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
128
New
Increased
Reduced
Closed

Top Buys

1 +$13.9M
2 +$6.07M
3 +$5.32M
4
ASND icon
Ascendis Pharma
ASND
+$5.14M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.07M

Top Sells

1 +$14.5M
2 +$11M
3 +$10.2M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$9.76M
5
SLNO icon
Soleno Therapeutics
SLNO
+$7.92M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$81.1B
$17M 11.81%
30,160
+24,553
SLNO icon
2
Soleno Therapeutics
SLNO
$2.03B
$12M 8.35%
177,330
-106,822
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$11.2B
$11.5M 8.03%
212,877
+20,000
PCVX icon
4
Vaxcyte
PCVX
$8.59B
$7.86M 5.48%
218,285
+20,000
INDV icon
5
Indivior Pharmaceuticals
INDV
$3.86B
$6.13M 4.27%
+254,252
BMY icon
6
Bristol-Myers Squibb
BMY
$125B
$5.86M 4.08%
+130,000
ASND icon
7
Ascendis Pharma
ASND
$14.7B
$5.48M 3.82%
+27,572
NBIX icon
8
Neurocrine Biosciences
NBIX
$13.2B
$5.3M 3.69%
37,754
-56,288
VKTX icon
9
Viking Therapeutics
VKTX
$3.69B
$5.09M 3.55%
193,689
-3,779
ALNY icon
10
Alnylam Pharmaceuticals
ALNY
$42.3B
$4.56M 3.18%
+10,000
IMCR icon
11
Immunocore
IMCR
$1.64B
$4.52M 3.15%
124,384
+20,000
NKTR icon
12
Nektar Therapeutics
NKTR
$1.91B
$4.27M 2.97%
+75,000
ABVX
13
Abivax
ABVX
$8.78B
$3.51M 2.45%
+41,620
PTGX icon
14
Protagonist Therapeutics
PTGX
$5.71B
$3.4M 2.37%
51,185
-25,000
JAZZ icon
15
Jazz Pharmaceuticals
JAZZ
$11.5B
$3.05M 2.12%
23,140
-81,333
ANIP icon
16
ANI Pharmaceuticals
ANIP
$1.71B
$2.88M 2%
+31,400
RVMD icon
17
Revolution Medicines
RVMD
$19.4B
$2.76M 1.92%
59,079
-20,000
APGE icon
18
Apogee Therapeutics
APGE
$4.68B
$2.55M 1.78%
64,250
+53,678
TERN icon
19
Terns Pharmaceuticals
TERN
$4.51B
$2.43M 1.69%
323,159
+63,307
ARDX icon
20
Ardelyx
ARDX
$1.51B
$2.2M 1.54%
+400,000
TGTX icon
21
TG Therapeutics
TGTX
$4.58B
$2.19M 1.53%
60,748
-310,700
ALKS icon
22
Alkermes
ALKS
$4.82B
$2.16M 1.51%
+72,079
ROIV icon
23
Roivant Sciences
ROIV
$19.9B
$1.82M 1.26%
+120,000
URGN icon
24
UroGen Pharma
URGN
$881M
$1.8M 1.25%
90,000
-60,000
PCRX icon
25
Pacira BioSciences
PCRX
$908M
$1.52M 1.06%
58,926